Newsletter | November 18, 2025

11.18.25 -- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?

SPONSOR

Spotlight the Best in CRO Partnerships—Share Your Voice!

Help shape the future of CRO excellence! Take part in the 2025 CRO Leadership Awards Survey, conducted by Tufts CSDD and Clinical Leader. Your confidential feedback will determine the top CROs in project management, services, culture, and more. Winners will be celebrated through Clinical Leader events—don’t miss your chance to spotlight outstanding collaboration in our industry!

FEATURED EDITORIAL

Why Do So Few Cell Therapies Make The Leap From Lab To GMP?

Among other reasons, academic centers have access to sophisticated technology. In contrast, manufacturing suites must use established, validated methods.

INDUSTRY INSIGHTS

Critical Supply Strategies For CROs

Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy.

SOLUTIONS

Supplies Pain Points — Production Guesswork